NCT04336761 (INCOVPED) is a clinical trial of nasopharyngeal swab in Coronavirus, sponsored by University Hospital, Lille.

Who is sponsoring NCT04336761?

NCT04336761 is sponsored by University Hospital, Lille.

What drugs are being tested in NCT04336761?

Interventions in NCT04336761: nasopharyngeal swab.

What condition does NCT04336761 study?

NCT04336761 studies Coronavirus, COVID, Infection Viral.

Is NCT04336761 still recruiting?

NCT04336761 is currently completed. Last updated 11 March 2021.

Last reviewed 2021-03-11 · How we verify

NCT04336761: INCOVPED

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France

Completed Last updated 11 March 2021

What this trial tests

trial testing nasopharyngeal swab in Coronavirus in 901 participants. Completed in 1 January 2021.

Timeline

15 April 2020

Primary endpoint
1 January 2021

1 January 2021

Quick facts

Lead sponsor	University Hospital, Lille
Status	Completed
Study type	OBSERVATIONAL
Enrollment	901
Start date	15 April 2020
Primary completion	1 January 2021
Estimated completion	1 January 2021
Sites	6 locations across France

Drugs / interventions tested

nasopharyngeal swab — full drug profile →

Conditions studied

Coronavirus — all drugs for Coronavirus →
COVID — all drugs for COVID →
Infection Viral — all drugs for Infection Viral →

Sponsor

University Hospital, Lille

Who can join

Under 18, any sex, with Coronavirus or COVID. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by this infection. It is estimated that the child could be asymptomatic or pauci-symptomatic carrier and thus be vector of the disease. For this reason, measures have been taken to close schools and contain populations in a large number of countries, including France. However, there are no data on the prevalence of COVID-19 in children.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
Woudenberg T, Pelleau S, Anna F, Attia M, et al · · 2021 · cited 65× · PMID 34304047 · DOI 10.1016/j.ebiom.2021.103495
Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France.
De Thoisy A, Woudenberg T, Pelleau S, Donnadieu F, et al · · 2023 · cited 12× · PMID 37496603 · DOI 10.1093/ofid/ofad340
Integrated Serosurveillance of Infectious Diseases Using Multiplex Bead Assays: A Systematic Review.
Ward S, Lawford HLS, Sartorius B, Lau CL. · · 2025 · cited 3× · PMID 39852670 · DOI 10.3390/tropicalmed10010019

Verify or expand the search:

Other trials of nasopharyngeal swab

Trials testing the same drug.

NCT07166744 — Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies · NA · not yet recruiting
NCT04355533 — Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 · NA · completed
NCT04078997 — An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi · completed
NCT03698084 — RESCEU: Defining the Burden of RSV Disease · active not recruiting
NCT02928367 — The Effect of Leukocyte Dna mEthylation and micRoBIOME Diversity on Host Defense Mechanisms During Community-acquired Pn · unknown

Other recruiting trials for Coronavirus

Currently open trials in the same condition.

NCT04772170 — Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies · recruiting
NCT05868239 — Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study · NA · recruiting
NCT04359836 — A Study to Explore the Role of Gut Flora in COVID-19 Infection · recruiting
NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting
NCT04568148 — COVID-19 Biorepository · active not recruiting

Other University Hospital, Lille trials

Trials by the same sponsor.

NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04336761 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
Last refreshed: 11 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04336761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing